Related Experiment Video
Updated: Jun 11, 2025

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.1K
Are Women's Breast Cancer Risk Appraisals in Line with Updated Clinical Risk Estimates Communicated? Results from a
Victoria G Woof1, Anthony Howell1,2, Lynne Fox2
1University of Manchester, Manchester, United Kingdom.
Summary
Women accurately updated their breast cancer risk perceptions after receiving new information, including breast density and polygenic risk score (PRS) data. This suggests risk communication strategies can effectively change personal risk appraisals.
Area of Science:
- Oncology
- Genetics
- Risk Assessment
Background:
- Breast cancer risk prediction models increasingly incorporate factors like breast density and polygenic risk scores (PRS).
- Previous studies indicate risk communication often fails to alter personal risk appraisals.
- This study investigates how women's risk perceptions change after receiving updated breast cancer risk estimates.
Purpose of the Study:
- To examine how women appraise their breast cancer risk after receiving updated risk estimates.
- To assess the integration of new risk factors (breast density, PRS) into women's risk perceptions.
- To evaluate the impact of risk communication strategies on risk appraisal.
Main Methods:
- 323 women received updated breast cancer risk estimates in a family history risk study.
- A subset of 190 women completed questionnaires on subjective risk, satisfaction, and worry.
- Risk notifications included decreased, increased, or unchanged risk categories.
Main Results:
- Women's subjective risk appraisals aligned with updated estimates.
- Age, PRS, and breast density significantly influenced risk appraisals.
- Those with increased risk notifications reported higher subjective risk perceptions.
Conclusions:
- Subjective breast cancer risk appraisals are modifiable with updated risk feedback.
- New information, including breast density and PRS, was integrated into risk appraisals.
- Effective communication strategies may enhance the acceptance of updated risk information.
Related Concept Videos
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91

